Literature DB >> 15291355

Polymorphisms of p53 Arg72Pro, p73 G4C14-to-A4T14 at exon 2 and p21 Ser31Arg and the risk of non-Hodgkin's lymphoma in Japanese.

Asahi Hishida1, Keitaro Matsuo, Kazuo Tajima, Michinori Ogura, Yoshitoyo Kagami, Hirofumi Taji, Yasuo Morishima, Nobuhiko Emi, Tomoki Naoe, Nobuyuki Hamajima.   

Abstract

We hypothesized that the polymorphisms in the two p53 family genes (p53 Arg72Pro and p73 G4C14-to-A4T14 at exon 2 (G4A)) and p21 Ser31Arg polymorphism might modulate the risk of non-Hodgkin's lymphoma, and conducted a hospital-based prevalent case control study at Aichi Cancer Center Hospital to clarify the association. Risk estimation for each genotype by the unconditional logistic model demonstrated the possible association between the p53 Pro72 allele and the risk of non-Hodgkin's lymphoma in Japanese population (OR = 1.59; 95% CI, 0.99-2.57, P = 0.057), although no other significant association was observed. The analyses of statistical interactions between these three polymorphisms (p73 G4A, p53 Arg72Pro and p21 Ser31Arg polymorphisms) revealed the marginally significant OR for interaction between p53 Arg72Pro and p73 G4A polymorphisms (OR = 2.54; 95% CI, 0.97 6.62, P = 0.057). When those without p53 Pro72 and p73 A4T14 alleles were defined as a reference, those with p53 Pro72 and p73 A4T14 alleles demonstrated a significantly higher OR (2.08; 95% CI, 1.11-3.90, P = 0.023). Further examination with a sufficiently larger population and other ethnicities are required to confirm our findings.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 15291355     DOI: 10.1080/10428190310001638878

Source DB:  PubMed          Journal:  Leuk Lymphoma        ISSN: 1026-8022


  10 in total

Review 1.  Dysfunction of the TP53 tumor suppressor gene in lymphoid malignancies.

Authors:  Zijun Y Xu-Monette; L Jeffrey Medeiros; Yong Li; Robert Z Orlowski; Michael Andreeff; Carlos E Bueso-Ramos; Timothy C Greiner; Timothy J McDonnell; Ken H Young
Journal:  Blood       Date:  2012-01-24       Impact factor: 22.113

2.  Combined analysis of the association between p73 G4C14-to-A4T14 polymorphisms and cancer risk.

Authors:  Lan Wang; Rui Gao; Long Yu
Journal:  Mol Biol Rep       Date:  2011-05-27       Impact factor: 2.316

Review 3.  Genetic susceptibility to lymphoma.

Authors:  Christine F Skibola; John D Curry; Alexandra Nieters
Journal:  Haematologica       Date:  2007-07       Impact factor: 9.941

4.  p53 codon 72 polymorphism and hematological cancer risk: an update meta-analysis.

Authors:  Yu Weng; Liqin Lu; Guorong Yuan; Jing Guo; Zhizhong Zhang; Xinyou Xie; Guangdi Chen; Jun Zhang
Journal:  PLoS One       Date:  2012-09-24       Impact factor: 3.240

5.  Impact of TP53 codon 72 and MDM2 SNP 309 polymorphisms in pancreatic ductal adenocarcinoma.

Authors:  Yasuki Hori; Katsuyuki Miyabe; Michihiro Yoshida; Takahiro Nakazawa; Kazuki Hayashi; Itaru Naitoh; Shuya Shimizu; Hiromu Kondo; Yuji Nishi; Shuichiro Umemura; Akihisa Kato; Hirotaka Ohara; Hiroshi Inagaki; Takashi Joh
Journal:  PLoS One       Date:  2015-03-03       Impact factor: 3.240

6.  Association between p21 Ser31Arg polymorphism and cancer risk: a meta-analysis.

Authors:  Hongxia Ma; Ziyuan Zhou; Sheng Wei; Qingyi Wei
Journal:  Chin J Cancer       Date:  2011-04

7.  TP53 Arg72 as a favorable prognostic factor for Chinese diffuse large B-cell lymphoma patients treated with CHOP.

Authors:  Yalu Liu; Xiaogan Wang; Ning Ding; Lan Mi; Lingyan Ping; Xuan Jin; Jiao Li; Yan Xie; Zhitao Ying; Weiping Liu; Chen Zhang; Lijuan Deng; Yuqin Song; Jun Zhu
Journal:  BMC Cancer       Date:  2017-11-10       Impact factor: 4.430

8.  TP73 G4C14-A4T14 polymorphism and cancer susceptibility: evidence from 36 case-control studies.

Authors:  Jialin Meng; Shuo Wang; Meng Zhang; Song Fan; Li Zhang; Chaozhao Liang
Journal:  Biosci Rep       Date:  2018-12-14       Impact factor: 3.840

9.  A Case-Control Study on the p73 G4A Gene Polymorphism and Susceptibility to Breast Cancer in an Iranian Population.

Authors:  Zeinab Tavakkol Afshari; Zahra Gholizadeh; Amin Reza Nikpoor; Jalil Tavakkol Afshari; Rashin Ganjali; Fatemeh Homaei Shandiz; Khadijeh Jamialahmadi
Journal:  Iran J Public Health       Date:  2019-10       Impact factor: 1.429

10.  Role of p73 Dinucleotide Polymorphism in Prostate Cancer and p73 Protein Isoform Balance.

Authors:  L Michael Carastro; Hui-Yi Lin; Hyun Y Park; Donghwa Kim; Selina Radlein; Kaia K Hampton; Ardeshir Hakam; Babu Zachariah; Julio Pow-Sang; Jong Y Park
Journal:  Prostate Cancer       Date:  2014-07-06
  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.